Medical News

---

• Caesarean section birth ‘may not increase wheezing risk in children’
• Postpartum mood episodes ‘do not influence disease course in BD’
• Sympathetic nervous system activity linked to schizophrenia relapse
• Cytosponge device promising for Barrett’s esophagus screening
• Association between TFPI polymorphisms and VTE risk unclear
• SITS-ISTR highlights hyperglycemia impact on thrombolysis outcomes
• Radiotherapy linked to complications after mastectomy with reconstruction
• Accurate treatment triggers needed for prostate cancer patients on surveillance
• Lymphocyte numbers predict metabolic syndrome risk
• Statins reduce risk for venous thromboembolism
• Vitamin D levels inversely correlated with incident diabetes in US women
• Add-on ezetimibe helps achieve lipid targets in Type 2 diabetics
• Increased CV risk with PPIs independent of concomitant clopidogrel
• Prevention better than cure for CHD

Caesarean section birth ‘may not increase wheezing risk in children’ Posted: 21 Sep 2010 05:00 PM PDT Results from a Brazilian study do not support previous findings of a link between cesarean section delivery and an increased risk for wheezing in children.

Postpartum mood episodes ‘do not influence disease course in BD’ Posted: 21 Sep 2010 05:00 PM PDT Results from a Spanish study suggest that postpartum mood episodes do not influence disease course and prognosis in women with bipolar disorder.

Sympathetic nervous system activity linked to schizophrenia relapse Posted: 21 Sep 2010 05:00 PM PDT Increased sympathetic nervous system activity may indicate an increased risk for psychotic relapse in the following 2-week period in patients with schizophrenia, results from a preliminary study suggest.

Cytosponge device promising for Barrett’s esophagus screening Posted: 21 Sep 2010 05:00 PM PDT An ingestible esophageal sampling device known as a Cytosponge is effective and well-tolerated for diagnosis of Barrett's esophagus, show study findings published in the British Medical Journal.

Association between TFPI polymorphisms and VTE risk unclear Posted: 20 Sep 2010 05:00 PM PDT Polymorphisms in the tissue factor pathway inhibitor type 1 gene modify the expression of its protein, which may in turn increase the risk for venous thromboembolism, according to Norwegian researchers.

SITS-ISTR highlights hyperglycemia impact on thrombolysis outcomes Posted: 20 Sep 2010 05:00 PM PDT Admission hyperglycemia is a strong predictor of symptomatic intracerebral hemorrhage and poor functional outcome among stroke patients undergoing thrombolysis, shows an analysis of the SITS-ISTR.

Radiotherapy linked to complications after mastectomy with reconstruction Posted: 20 Sep 2010 05:00 PM PDT Nearly half of women who have radiation therapy following a mastectomy with immediate breast reconstruction suffer complications that require further surgery, study findings indicate.

Accurate treatment triggers needed for prostate cancer patients on surveillance Posted: 20 Sep 2010 05:00 PM PDT The standard prostate-specific antigen measurements used to evaluate low-risk prostate cancer patients on watchful waiting programs may result in many being unnecessarily triggered for active treatment, says a Canadian research team.

Lymphocyte numbers predict metabolic syndrome risk Posted: 20 Sep 2010 05:00 PM PDT Circulating levels of lymphocytes are strongly associated with the risk for the metabolic syndrome, a UK study has found.

Statins reduce risk for venous thromboembolism Posted: 20 Sep 2010 05:00 PM PDT The use of statins can prevent a large proportion of venous thromboembolism events, a meta-analysis has found.

Vitamin D levels inversely correlated with incident diabetes in US women Posted: 20 Sep 2010 05:00 PM PDT Blood levels of vitamin D are inversely associated with the risk for developing Type 2 diabetes in women, independently of other risk factors, a case–control study suggests.

Add-on ezetimibe helps achieve lipid targets in Type 2 diabetics Posted: 20 Sep 2010 05:00 PM PDT Adding ezetimibe to simvastatin therapy helps diabetes patients reach their lipid targets, a randomized, controlled trial has found.

Increased CV risk with PPIs independent of concomitant clopidogrel Posted: 20 Sep 2010 05:00 PM PDT Myocardial infarction patients taking proton-pump inhibitors in isolation may have an increased risk for adverse cardiovascular events similar to those taking PPIs with concomitant clopidogrel, a Danish study suggests.

Prevention better than cure for CHD Posted: 20 Sep 2010 05:00 PM PDT Researchers report that recent declines in death from coronary heart disease in the US are largely attributable to reductions in modifiable risk factors such as systolic blood pressure.

You are subscribed to email updates from MedWire Medical News Combined Feed To stop receiving these emails, you may unsubscribe now.	Email delivery powered by Google
Google Inc., 20 West Kinzie, Chicago IL USA 60610